Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Strs Ohio

Strs Ohio lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 87.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,100 shares of the company's stock after selling 14,400 shares during the quarter. Strs Ohio's holdings in Prestige Consumer Healthcare were worth $128,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Provence Wealth Management Group acquired a new stake in Prestige Consumer Healthcare during the third quarter worth $26,000. Pacer Advisors Inc. boosted its position in shares of Prestige Consumer Healthcare by 85.7% during the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company's stock worth $27,000 after buying an additional 204 shares during the period. ORG Partners LLC purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $36,000. International Assets Investment Management LLC boosted its position in shares of Prestige Consumer Healthcare by 1,900.0% during the fourth quarter. International Assets Investment Management LLC now owns 980 shares of the company's stock worth $60,000 after buying an additional 931 shares during the period. Finally, Dfpg Investments LLC boosted its position in shares of Prestige Consumer Healthcare by 11.7% during the fourth quarter. Dfpg Investments LLC now owns 4,273 shares of the company's stock worth $258,000 after buying an additional 447 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Insider Activity at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 5,336 shares of the business's stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the transaction, the senior vice president now owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on PBH shares. StockNews.com upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, February 10th. TheStreet raised Prestige Consumer Healthcare from a "c+" rating to a "b-" rating in a report on Monday, February 12th. One investment analyst has rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $110.00.

Prestige Consumer Healthcare Stock Performance

Shares of PBH traded down $0.64 during midday trading on Wednesday, reaching $71.12. 231,588 shares of the stock were exchanged, compared to its average volume of 236,158. The business's 50-day moving average price is $71.08 and its 200 day moving average price is $64.49. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.09 and a quick ratio of 1.92. Prestige Consumer Healthcare Inc. has a twelve month low of $55.96 and a twelve month high of $75.31. The company has a market capitalization of $3.53 billion, a price-to-earnings ratio of -43.37, a PEG ratio of 1.95 and a beta of 0.52.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.02. The business had revenue of $282.74 million for the quarter, compared to analysts' expectations of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The business's revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.04 earnings per share. On average, sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.